KMID : 1035620140020050394
|
|
Allergy Asthma & Respiratory Disease 2014 Volume.2 No. 5 p.394 ~ p.397
|
|
Successful desensitization for cytarabine induced anaphylaxis
|
|
ÀÌÇö¿ì:Lee Hyun-Woo
¹ÚÀç¿ë:Park Jae-Yong/¹®ÁØÈ£:Moon Joon-Ho/¹Ú°æÅÃ:Park Kyung-Taek/¹ÚÇѱâ:Park Han-Ki/°Çý·Ã:Kang Hye-Ryun
|
|
Abstract
|
|
|
Cytarabine is a very important chemotherapeutic agent for leukemia and lymphoma patients and is prescribed more frequently than before. Cytarabine-induced delayed-onset hypersensitivity may rarely present as non-IgE mediated anaphylaxis. However, we do not know yet whether desensitization therapy in adults may be effective in cytarabine-induced delayed-onset anaphylaxis. A 78-year-old woman who was diagnosed with acute myeloblastic leukemia had chemotherapy including cytarabine. In spite of premedication with hydrocortisone and chlorpheniramine, the patient had anaphylaxis a few hours after cytarabine infusion. We decided to perform desensitization therapy. After desensitization therapy using a newly designed protocol, the patient was tolerable to cytarabine infusion without hypotension or high fever. Desensitization therapy was successfully performed on an adult patient with delayed-onset anaphylaxis caused by cytarabine.
|
|
KEYWORD
|
|
Anaphylaxis, Cytarabine, Immunologic desensitization
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|